LSE - Delayed Quote GBp

Oxford Nanopore Technologies plc (ONT.L)

127.90
+0.40
+(0.31%)
As of 11:33:50 AM GMT+1. Market Open.

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.
NameTitlePayExercisedYear Born
Dr. Gurdial Singh Sanghera Ph.D. Co-Founder, CEO, Chief Officer of Technology, Innovation & Products and Director 1.69M -- 1961
Mr. Nicholas Patrick Keher CFO & Director 763.11k -- 1982
Mr. Timothy Cowper Chief Operating Officer 422.79k -- 1965
Dr. James Spike Willcocks Chief Strategy Officer 543.27k -- 1976
Prof. Hagan Bayley Ph.D. Co-Founder & Member of Technical Advisory Board -- -- --
Mr. Lakmal Jayasinghe Chief Scientific Officer -- -- --
Mr. Jordan Herman Senior VP & General Counsel -- -- --
Mr. John Schoellerman Senior Vice President of Corporate & Business Development -- -- --
Ms. Rosemary Sinclair Dokos M.B.A. Chief Product & Marketing Officer -- -- --
Mr. Richard Compton Senior Vice President of Sales & Commercial Operations -- -- --

Oxford Nanopore Technologies plc

Gosling Building
Edmund Halley Road Oxford Science Park
Oxford, OX4 4DQ
United Kingdom
44 84 5034 7900 https://nanoporetech.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
1,382

Description

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows the real-time analysis of DNA or RNA. It offers MinION Mk 1D, a portable device for DNA and RNA; GridION and GridION Q, a compact bench top device, which delivers a version of hardware, software, and chemistry. The company also provides PromethION 2 Solo, PromethION 2, PromethION 24, and PromethION 48. Its platform enables its customers to perform scientific/biomedical research in a various area, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science. It operates in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific. The company was formerly known as Oxford NanoLabs Limited and changed its name to Oxford Nanopore Technologies plc in May 2008. Oxford Nanopore Technologies plc was incorporated in 2005 and is headquartered in Oxford, the United Kingdom.

Corporate Governance

Oxford Nanopore Technologies plc’s ISS Governance QualityScore as of May 1, 2025 is 6. The pillar scores are Audit: 2; Board: 5; Shareholder Rights: 10; Compensation: 6.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

March 4, 2025 at 7:00 AM UTC

Oxford Nanopore Technologies plc Earnings Date

Recent Events

Related Tickers